| Brainwide mendelian randomization study of anxiety disorders and symptoms MD Zanoaga, E Friligkou, J He, GA Pathak, D Koller, B Cabrera-Mendoza, ... Biological Psychiatry 95 (8), 810-817, 2024 | 8 | 2024 |
| Pleiotropy and genetically inferred causality linking multisite chronic pain to substance use disorders D Koller, E Friligkou, B Stiltner, GA Pathak, S Løkhammer, DF Levey, ... Molecular psychiatry, 1-10, 2024 | 2 | 2024 |
| Integrating genome-wide information and wearable device data to explore the link of anxiety and antidepressants with heart rate variability E Friligkou, D Koller, GA Pathak, EJ Miller, R Lampert, MB Stein, ... medRxiv, 2023.08. 02.23293170, 2023 | 2 | 2023 |
| Gene Discovery and Biological Insights into Anxiety Disorders from a Multi-Ancestry Genome-wide Association Study of> 1.2 Million Participants E Friligkou, S Lokhammer, B Cabrera Mendoza, J Shen, J He, G Deiana, ... medRxiv, 2024.02. 14.24302836, 2024 | 1 | 2024 |
| Distinguishing vulnerability and resilience to posttraumatic stress disorder evaluating traumatic experiences, genetic risk and electronic health records S Løkhammer, D Koller, FR Wendt, KW Choi, J He, E Friligkou, ... Psychiatry Research 337, 115950, 2024 | | 2024 |
| Sex differences in the associations of socioeconomic factors and cognitive performance with family history of Alzheimer’s disease J He, B Cabrera-Mendoza, E Friligkou, AP Mecca, CH van Dyck, ... medRxiv, 2024.06. 12.24308850, 2024 | | 2024 |
| Genetic contribution to the comorbidity between attention-deficit/hyperactivity disorder and substance use disorders D Koller, M Mitjans, M Kouakou, E Friligkou, B Cabrera-Mendoza, ... Psychiatry Research 333, 115758, 2024 | | 2024 |
| Sleep inertia drives the association of evening chronotype with psychiatric disorders: epidemiological and genetic evidence AC Burns, S Zellers, DP Windred, I Daghlas, N Sinnott-Armstrong, ... medRxiv, 2024.09. 10.24313197, 2024 | | 2024 |
| Genetics of posttraumatic stress disorder and cardiovascular conditions using Lifes Essential 8, Electronic Health Records, and Heart Imaging J Shen, W Valentim, E Friligkou, C Overstreet, KW Choi, D Koller, ... medRxiv, 2024.08. 20.24312181, 2024 | | 2024 |
| T18. GENETIC CONTRIBUTION TO THE COMORBIDITY BETWEEN ATTENTION-DEFICIT HYPERACTIVITY DISORDER AND SUBSTANCE USE DISORDERS D Koller, M Mitjans, M Kouakou, E Friligkou, BC Mendoza, J Deak, ... European Neuropsychopharmacology 75, S171, 2023 | | 2023 |
| T4. FINGER ON THE PULSE: INTEGRATING GENETIC AND WEARABLE DATA TO EXPLORE THE LINK BETWEEN HEART RATE VARIABILITY, ANXIETY, AND ANTIDEPRESSANTS E Friligkou, D Koller, G Pathak, EJ Miller, R Lampert, MB Stein, ... European Neuropsychopharmacology 75, S164, 2023 | | 2023 |
| 32. Defining Major Depression Sub-Phenotypes: A Multivariate Polygenic Risk Score Approach E Friligkou, G Pathak, D Koller, R Polimanti Biological Psychiatry 93 (9), S107, 2023 | | 2023 |
| A co-phenome analysis into genetic resilience and vulnerability of posttraumatic stress disorder S Løkhammer, D Koller, FR Wendt, E Friligkou, C Overstreet, J Gelernter, ... Neuroscience Applied 2, 103871, 2023 | | 2023 |
| Genetic overlap and causal relationship between multisite chronic pain and substance use disorders D Koller, E Friligkou, G Pathak, B Stiltner, DF Levey, H Zhou, A Hatoum, ... Neuroscience Applied 2, 102822, 2023 | | 2023 |
| A GENOME-WIDE CROSS-DISORDER ANALYSIS OF BIPOLAR DISORDER, SCHIZOPHRENIA, AND DEPRESSION REVEALS NOVEL PLEIOTROPIC LOCI AND PATHWAYS E Friligkou, F Wendt, GA Pathak, D Tylee, F De Angelis, A De Lillo, ... European Neuropsychopharmacology 63, e254-e255, 2022 | | 2022 |
